Exam 1 Flashcards

1
Q

Two conditions to be qualified as mental illness

A

1.) the syndrome results from an inability of some internal mechanism, or process to perform its natural function. (cognitive, behavioral, emotional)

2.) the syndrome is associated with significant distress or impairment in social, occupational, or other important activities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

1800s classification system of mental illness

A
  • 1840s: idiocy/insanity
  • 1880s: seven mental illnesses: mania, melancholia, monomania, paresis, dementia, dipsomania, and epilepsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

1900s classification of mental illness

A

1.) 1918: statistical manual for the use of institutions for the insane— 22 disorders

2.) 1933: standard classified nomenclature of disease— 24 major categories

3.) 1940s: the VA system created the diagnostic and statistical manual (DSM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which DSM overhaul was motivated by an attempt to legitimize the field of psychiatry and psychiatric diagnosis?

A

DSM III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Revisions following the DSM III REFLECTED WHAT TREND IN PSYCHIATRY?

A

Medicalization, including clinical significance criterion, and culture bound syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Three issues with the DSM IV

A

1.) basic definition of mental illness.
2.) use of categorical rather than dimensional criteria for certain diagnosis
3.) the need to address various expressions of mental illness across the lifespan, genders and culture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DSM 5 is:

A

• a living document- scientific advances are rapidly Inc.
• focus on neurobiological etiology
• dimensional diagnoses would be favored over categorical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Two Major differences in the DSM5

A

1.) additional attention to culture racism and discrimination incorporated information on cultural influences on disorder characteristics.

2.) ethical, racial equity, and inclusion work group. Alter the language to avoid perpetuating stereotypes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most prevalent 12 month mental disorders in adults

A

Anxiety > depression> somatic symptom disorders > PTSD > dual diagnosis > suicidal ideation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What percent of patients with mental illness have a comorbid medical condition?

A

68%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The average delay between the onset of mental illness, and the treatment is

A

11 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Depression screenings

A

PHQ9, PHQ2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anxiety screenings

A

GAD7, GAD2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Psychiatric interview— review of systems

A
  1. Identifying information
  2. History of present symptoms
  3. Social and behavioral history
  4. Medical history/substance use history
  5. Family medical in psychiatric history
  6. Assessment measures
  7. Formal DSM5 diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Components of a mental status examination

A

1.) general observations (appearance, speech, behavior)
2.) thinking
3.) emotion (mood/affect)
4.) cognition (orientation, attention, memory)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mini mental state exam MMSE

A

One of the most common cognitive screening tests used by physician in office settings
— 30 point screening tool, including orientation, language, functions, registration, attention, visuospatial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Scoring for MMSE

A

24-30: normal
18-23: mild cognitive impairment
0-17: severe cognitive impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is another cognitive assessment used in clinic?

A

Montreal cognitive assessment (moCA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Neuropsychological examinations

A

1.) intelligence tests.
2.) neurocognitive test and batteries
3.) personality tests

Most common: Halstead-Reitan neuropsychological test battery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Alfred Binet

A

French psychologist who developed the first practical intelligence test in order to identify elementary students in need of academic assistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lewis Terman and William Stern

A
  • Expanded Binet’s work, Stanford-Binet intelligence test
  • Stern came up with the intelligence quotient score (IQ)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Early intelligent quotient calculation

A

MA/CA x 100

• mental age/chronological age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Common intelligence tests

A

1.) Wechsler adult intelligence scale
2.) Wechsler intelligence scale for children
3.) wechsler preschool in primary scale of intelligence
4.) Bayley scales of infant and toddler development
5.) Stanford-Binet fifth edition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Bell curve for IQ score

A
  • 1SD: 68.2% (34.1%)
    -2 SD: 95.4% (13.6%)
    -3 SD: 99.6% (2.1%)
    -4 SD: 99.8% (0.1%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Problem with intelligence testing
They are racially and culturally biased to the white middle class — Larry P versus Riles case
26
Projective personality test
Design to reveal hidden emotions and internal conflicts through a persons responses to ambiguous stimuli (Rorschach test— ink blot)
27
Objective personality assessment
Use a restricted response format like true/false and contain extensively tested validity skills to determine whether the person taking the test is truthful — Minnesota multiphasic personality inventory (MMPI)
28
Rorschach test administration
1.) free association phase 2.) inquiry phase — interpretation is complex and based on several aspects of the subjects response
29
MMPI
• current version is MMPI-3, containing 335 true/false items • 52 scales (10 validity scales)
30
MMPI is frequently used for;
1. Aid in clinical diagnosis 2. Police selection process. 3. Compensation and pension cases for veterans 4. Legal disputes (custody battles)
31
Upper motor neurons
Motor cortex: planning initiating and directing voluntary movement Brainstem: postural control, locomotion, basic voluntary movement
32
Lower motor neurons
Spinal cord and brain stem circuits: reflexes Skeletal muscles: contraction
33
Corticobulbar tract
Origin: M1, premotor, SMA, somatosensory cortex Target: medullary pyramids (cranial nerve nuclei, reticular formation, red nucleus)
34
Corticospinal tract
Origin: M1, premotor, SMA, somatosensory cortex At caudal medulla: 90% decussate (lateral innervates distal limb muscles, ventral, innervates, axial, and proximal limb muscles) Target: lower motor neurons with collaterals to the red nucleus and reticular formation
35
Alpha motor neuron:
Contracts the muscle
36
Rubrospinal tract
Origin: red nucleus Decussates immediately and travels in the lateral medulla Target: motor neurons near the lateral corticospinal tract in the upper spinal cord (cervical, thoracic) — control of the arms
37
Rubrospinal tract, Parvocellular
Input: cerebellum Output: inferior olive
38
Rubrospinal tract, magnocellular
Input: motor cortex Output: spinal cord
39
Medial vestibulospinal tract
• terminates bilaterally in the medial ventral horn of the spinal cord, to regulate the head position
40
Lateral vestibulospinal tract
• terminates bilaterally in the medial ventral horn of the spinal cord, and activates the antigravity muscles in limbs when deviations from stable posture are detected
41
The two nuclei of the reticulospinal tract
1. Pontine reticular formation 2. Medullary reticular formation • both terminate in the medial ventral horn of the spinal cord— they coordinate bilateral movements of the trunk and proximal limbs • postural control, locomotion
42
The goal of posture control
Keep the center of mass above the support surface. This is done by muscle tone providing force in the opposite direction of the shift in order to maintain balance.
43
Definition of postural tone:
1.) tonic activity in the muscles, physiological extensors 2.) tonic firing of alpha motor neurons providing the mechanism
44
Two ways to increase alpha motor neuron activity
1.) directly increase, alpha motor, neuron input from descending tracts 2.) indirectly increase gamma motor, neuron activity to create a feedback loop
45
Feedback
• vestibulospinal tract • sense, environmental disturbance of body position, and stability
46
Feedforward (anticipatory)
• reticulospinal tract • stabilized posture during ongoing movements through inputs from cerebral cortex, hypothalamus, brainstem
47
Vestibulocolic reflex
Acts on neck muscles to adjust the head and stabilize it in space
48
Vestibulospinal reflex
Adjust axial and proximal limbs
49
Inputs and outputs of the vestibulospinal tract in postural control
Input: vestibular end organs: otoliths and semicircular canals, cerebellum Output: alpha and gamma motor neurons
50
Responsible descending systems for anticipatory maintenance of body posture
1.) reticulospinal - proximal and axial muscle control 2.) corticospinal - voluntary motor function 3.) Rubrospinal - moves arms — feedforward adjustment example: proximal leg muscles contract before by serves to ensure posture stability
51
What does the cortex inhibit in order to modulate tone?
Gamma motor neurons
52
Lesion of the corticospinal tract results in:
Loss of fine voluntary movements of the hand
53
Upper motor neuron syndrome
• spinal shock: loss of find voluntary movements, flaccidity • alpha and gamma motor neurons lose their excitatory inputs from the central nervous system
54
Symptoms of upper motor neuron syndrome
+ Babinski sign, spasticity: increased muscle tone, hyperreflexia, clonus, loss of fine limb movements
55
Causes for spasticity in the upper motor neurons
1.) removal of cortical inhibition on postural centers (vestibular, nuclei, and reticular formation) 2.) sprouting, local axon collaterals to make more synapses (homeostatic plasticity) 3.) increased receptor sensitivity of motor neurons do to denervation (homeostatic plasticity)
56
Decorticate
• damage above the red nucleus, loss of cortical modulation • posture: upper extremities in flexion, lower extremities in extension
57
Decerebrate
• damage below red nucleus, loss of Rubrospinal tract. No modulation of reticulospinal tract, vestibulospinal tract still intact • posture: all limbs in extension
58
Loss of all of the descending motor tracks will result in:
Flaccidity and death
59
Spinal cord transection
• more severe- spinal shock • loss of fine voluntary movements, flaccidity, but preserved trunk muscles caused from the shock • persistent effect: + Babinski, spasticity, loss of fine limb movements
60
Lower motor neuron syndrome
• flaccid paralysis with little or no muscle tone • muscle atrophy • fasciculation and fibrillations on EMG
61
Withdrawal reflex
• polysynaptic reflex that occurs in response to nociceptive stimulation • response is contraction of flexor muscles and inhibition of extensor muscles so that stimulated part is withdrawn from the stimulus
62
Reciprocal inhibition
Collateral branches of the afferent fibers activate inhibitory interneurons that suppress the activity of alpha motor neurons that innervate antagonist muscles
63
Stretch (muscle spindle) reflex
• patellar reflex • typically seen as monosynaptic (alpha motor neurons) must have reciprocal inhibitory and gamma motor neurons
64
Gamma motor neurons purpose
Keep appropriate amount of tension in the intrafusal fibers to maintain spindle sensitivity, a.k.a. maintain tone
65
Inverse stretch (Golgi tendon) reflex
• inverse = inhibitory interneuron • load is dropped because muscle relaxes instead of flexing
66
Lengthening reaction
1.) stretch reflex = contraction, light weight 2.) inverse stretch reflex = relaxation, heavy weight — typically coordinated, so that adjustment of muscle tension occur seamlessly
67
Spasticity
LMN lesion: flaccid paralysis UMN lesion: reduced inhibitory inputs to gamma motor neurons (fine motor function) —> hypertonic, spastic paralysis
68
Clasp knife reflex— UMN lesion
As a limb is moved passively and rapidly, there is rigidity (catch) followed by activation of the inverse stretch reflex (relax)
69
Rigidity
• increase in excitatory, or decrease in inhibitory signals to Alpha motor, neurons, leading to contraction of extrafusal fibers and generation of force independent of stretch reflex pathways
70
Lead pipe rigidity
Constant rigidity, slow and stiff in every direction all the time
71
Cogwheel rigidity
Resembles clasp knife, it is lead pipe, rigidity, coupled with a tremor
72
Central pattern generators
Groups of neurons, who is activation result in stereotyped movements (fixed action patterns— once started you get the same movement every time) Ex: blinking, vomiting, locomotion
73
Spinal locomotor center
• proprioceptive feedback initiates bilaterally in lower thoracolumbar spine, resulting in rhythmic activation of lectures and extensors in order to walk • stepping reflex in babies— not born with this
74
Mesencephalic locomotor center
• proposed converging structure • regulates, duration (pace) of stepping as well as initiation and cessation
75
Pontomedullary reticular formation locomotor center
• coordination of movements on one side of the body with postural control on the other— opposite compensation
76
Actions of the brain stem locomotor centers are modified by descending control originating in:
• primary motor cortex • supplementary motor area • basal ganglia
77
What is the purpose of gamma motor neurons in a person was normal upper motor neuron function?
Maintain tension in intrafusal muscle fibers
78
What is most likely to be uniquely exhibited in a patient with an upper motor neuron lesion?
Clasp knife reflex
79
What are the locomotor centers?
1.) spinal 2.) mesencephalic 3.) Pontomedullary reticular formation
80
Cerebellum
- Sensory motor coordination - Connects with UMNs and primary motor cortex to create feedback loops
81
Cerebellar cortex includes
Vermis, paravermis (in the medial cerebellum), hemispheres
82
Cerebellar nuclei includes
Fastigial, interposed, dentate
83
Cerebellar peduncles
Superior, middle, and inferior
84
Three cerebellar layers
1.) Molecular: contains stellate cells, parallel fibers, and basket cells 2.) Purkinje: purkinje cells 3.) Granule: Granular cells, golgi cells, mossy fibers, purkinje cell axons, and climbing fibers
85
Purkinje cells
the only output neuron, inhibit (GABA) cerebellar nuclei/vestibular nucleus
86
Granule cells
origin of parallel fibers, excitatory (glutamate) with three interneurons: Stellate, basket, and golgi cells
87
Golgi cells
inhibitory (GABA), all excited by parallel fibers
88
Mossy fiber circuitry
Mossy fibers--> granule cells --> parallel fibers (+) --> purkinje cells
89
Climbing fibers (+) excite:
purkinje cells
90
Basket cells (-) inhibit:
purkinje cells
91
stellate cell s(-) inhibit:
purkinje cells
92
Purkinje cells (-) inhibit:
cerebellar nuclei and vestibular nucleus (medial and lateral) cerebellar nuclei --> central nervous system
93
Mossy fibers
- from multiple spinal and brainstem sites - synapse on granule cells (excitatory) - produce simple spikes (discrete, individual) - high frequency discharge -encode temporal and intensity of sensory and motor information
94
Climbing fibers
- Solely from contralateral inferior olive - monosynaptic excitation to purkinje cells - generate complex spikes in purkinje cells - low frequency discharge - encode teaching signals for motor learning
95
Cerebellar cortex is:
- Ipsilaterally organized - The output of cerebellar circuitry inhibits movement
96
Function of spinocerebellum
output to motor cortex, medial and lateral descending systems: motor execution to produce adaptive smooth motor coordination
97
Function of Cerebrocerebellum
output to motor and premotor cortex: motor planning, cognition and affective function
98
Function of Vestibulocerebellum
Output to vestibular nuclei: balance and eye movements and postural maintenance (receives a huge amount of input)
99
Disorders of vestibulocerebellum
- disturbances of equilibrium and balance- fall towards side of lesion - nystagmus - loss of smooth pursuit eye movements
100
Disorders of spinocerebellum
- Disturbance of gait of vermis - Hypotonia - action tremor - limb ataxia/dysmetria - dysdiadochokinesia (disorder of timing) - decomposition of movements
101
Disorders of cerebrocerebellum
- ataxia of finest movements (hand shaping, writing) - cognitive deficits
102
Decomposition of movement
The breakdown of movements down into their component parts in order to execute the desired trajectory- sequence movements
103
Intention tremor
Produce involuntary tremor that increases when approaching the target (back and forth movement)
104
Dysdiadochokinesia
Difficulty in performing rapidly alternating movements (ex. palm up, palm down on hands)
105
Deficits in motor learning
example: VOR- lesions to the cerebellum prevent the adjustment of VOR
106
Inherited spinocerebellar ataxia (hypermetria)
prevents proper termination of movements, patient overreaches and comes back to target
107
Associative learning system
- receives a huge amount of sensory and motor input - learns to associate sensory feedback from actual movements with the intended motor output - modulates motor output to match expected sensory input - plays a role in non-motor cerebellar fxn
108
Reafference
sensory information from the periphery about motions actually occurring
109
Efference copy (corollary discharge)
Neural copy of the intended action (motor commands)
110
Cerebellar cognitive affective syndrome (CCAS)
1. Execution: planning, set-shifting, verbal fluency, abstract reasoning, working memory 2. Spatial cognition: visual spatial organization and memory 3. Personality: blunt affect, disinhibited and inappropriate behavior 4. Language: agrammatism, aprosodia SOCIAL BEHAVIOR CHANGES
111
Decreased firing of purkinje cells results in:
autistic-like behaviors (ex. Tsc1 protein deletion causing autism)
112
Movement disorders definition
excess or slow movements, unrelated to weakness or spasticity-- different from neuromuscular disorders
113
Hypokinetic
Akinesia, hypokinesia, bradykinesia, and rigidity Example: Parkinson's, Parkinsonism, ataxias
114
Hyperkinetic
Dyskinesias: excessive, often repetitive involuntary movements that intrude into the normal motor activity Example: Huntington's disease, dystonia, essential tremor, restless leg syndrome, Wilson's disease, Tourette syndrome, myoclonus
115
If the basal ganglia is affected:
involuntary or decreased movements, but not weakness or changes in reflexes. Basal ganglia = smooths out muscle movements
116
If the cerebellum is affected:
Loss of coordination. Cerebellum helps limbs smoothly and accurately, helps maintains balance
117
MPTP-induced Parkinson's
- impurity found in synthetic heroin - transforms into MPP+ - selective degeneration of dopaminergic neurons in SNc - similar findings in intoxication from Rotenone
118
Atypical Parkinson's
- Shares Parkinson's triad + other symptoms such as autonomic dysfunction (incontinence), eye involvement, frontal cortex (cognitive, psychiatric), bulbar involvement (speech) - Synucleinopathy and tauopathy
119
Ataxias
- Neuronal loss in cerebellum and brainstem - autosomal dominant (spinocerebellar ataxias) - autosomal recessive: Friedrich's ataxia, Niemann Pick, ataxia-telangiectasia - treatment: symptomatic, PT
120
Chorea (choreiform movement)
Rapid controllable movements such as tics or jerks commonly seen in Huntington's
121
Dystonia
- Sustained muscle contractions frequently causing twisting and repetitive movements, or abnormal postures - Primary: dystonia only clincal sign - Secondary: hereditary, acquired (head trauma, stroke, tumor, drugs), parkinsonian disorders
122
Treatment of dystonia
1. Anti-cholinergic drugs 2. GABA agonists 3. dopaminergic agents 4. Botulism toxin 5. DBS (GPi)
123
Essential Tremor
- Common, kinetic tremor of the arms > head > postural instability - Benign, however complex and progressive - 50% inherited, 4% prevalence - Treatment: propanolol, and primidone (anticonvulsant)
124
Restless leg syndrome
- Throbbing, pulling, creeping, or other unpleasant sensations in the legs and uncontrollable urge to move them - Primarily at night, moving legs relieves symptoms - Exhaustion and daytime fatigue - 10% prevalence, associated with loss of DA and basal ganglia dysfunction - Treatment: dopamine agonists, benzodiazepines, anti-convulsants
125
Tourette syndrome
- Motor and phonic tics, onset in childhood or adolescence that can be voluntarily suppressed - Comorbidities: ADHD, OCD - decreased activity of inhibitory neurons in cortico-striato-thalamo-cortical circuit (disinhibition)
126
Treatment of tourettes
- alpha2-agonists like guanfacine (ADHD) - 5-20% pts experienced sustained/worsened symptoms - 30-50% pts experience reduced tics - 50% pts experience complete tic remission
127
Wilson's disease
- Accumulation of Cu+ in the liver and brain - Autosomal recessive, loss of fxn of ATP7B - causes hepatitis, parkinsonism, psychiatric symptoms, SI, homicidal ideation, depression, and aggression - Treatment: diet changes and chelating agents
128
Myoclonus
Sudden, involuntary jerking of a muscle or group of muscles. Myoclonic twitches or jerks: sudden muscle contractions or relaxation -- uncontrolled twitching (hiccups) - treatment: Clonezepam (anticonvulsant), and barbiturates (sedatives)
129
Somatic Symptom disorder
- one or more somatic symptoms that are distressing and/or result in disruption of daily activities and function leading to excessive thoughts, feelings, or behaviors that are related to the somatic symptoms. - Somatic states lasts > 6 months
130
Risk factors of SSD
- anxiety or depression - alexithymia - history of trauma, abuse, or neglect (esp in childhood) - Lower SES
131
Clinical features of SSD
- large number or outpatient visits - frequent hospitalizations - repetitive subspecialty referrals - large number of diagnoses - multiple medications
132
Treatments of SSD
• schedule, regular follow up visits • perform physical exams on the focus area of discomfort each visit • avoid unnecessary tests, invasive treatments, referrals, and hospitalization • set limits on contact outside of schedule visits
133
Illness anxiety disorder
• preoccupation with having or acquiring a serious illness. Somatic symptoms are not present typically • specific illness that is feared may change, preoccupation must be present for > 6 months • excessive health related behaviors or exhibit maladaptive, health related avoidance
134
Treatment for illness anxiety disorder
• General: establish trust, history, taking and physical exam, identification of stressors, education • CBT • supportive therapy • pharmacotherapy: serotoninergic meds, benefit 70 to 80% of patients
135
Conversion disorder (functional neurological symptom disorder)
• one or more symptoms of altered voluntary motor or sensory function • clinical findings provide evidence of a mismatch between the symptom and recognized neurological condition • clinically significant distress or impairment in functioning likely to occur following stress
136
Conversion disorder, clinical subtypes
• motor symptoms or deficits: involuntary movements, seizures, paralysis, weakness • sensory symptoms or deficits: anesthesia, blindness or tunnel, vision, deafness
137
Astasia abasia
No neurological gait (bouncing) typically resulting from conversion disorder
138
What area of the brain shows increased activity in conversion disorder?
The limbic system
139
Treatment of conversion disorder
• general/conservative: reassurance, addressing stressors, protective environment • physical therapy • neurologist/psychiatrist and mental health study • psychotherapies/hypnosis
140
Good prognosis of conversion disorder
• onset following a clear stressor • prompt treatment • symptoms of paralysis, aphonia, and blindness
141
Poor prognosis of conversion disorder
• delayed treatment • symptoms of seizures or tremors
142
Psychological factors affecting other medical conditions
Psychological and/or behavioral factors adversely affect a separate medical condition: influence the course, interfere with the treatment, constitute health risks, influence the underlying pathophysiology Example: anxiety increasing asthma exacerbation
143
Factitious disorder
• intentionally exaggerates or induces signs and symptoms of illness • motivation is to assume the sick role • other incentives for the illness inducing behavior is absent Example: contaminating, PICC line with stool
144
Self-enhancement model of factitious disorder
• a means of increasing or protecting self-esteem • a way to blame failures on illness • can be brave/heroic with medical illness/sophisticated with knowledge
145
Munchhausen syndrome
• most severe form of factitious disorder • impostership, generally prestigious • pseudologia Fantastica (exaggeration of symptoms stories)
146
Factitious disorder by proxy
A person intentionally produces physical signs or symptoms in another person under the first person’s care. Most commonly mothers of young children.
147
Ganser’s syndrome
Characterized by the use of approximate answers. Example: 5+5= 9 or 11
148
Predisposing factors of factitious disorder
• true, physical disorders in childhood, leading to extensive medical treatment • employment as a medical paraprofessional • severe personality disorder (especially cluster B)
149
Factitious disorder comorbidities
• anxiety • depression • personality disorders • borderline personality disorder/ antisocial
150
Malingering
• the intentional production of feigning illness • motivated by external incentives (obtain drugs, financial compensation, avoid work/school/military service, evade criminal prosecution)
151
The basal ganglia:
Gates proper initiation of movement. At rest, the basal ganglia suppress all movement.
152
The basal ganglia circuit: direct pathway
1. The striatum receives excitatory glutamatergic input from cortex 2. Striatum sends inhibitory GABA signal to internal Globus pallidus 3. Internal Globus pallidus produces less of its own GABA—> Les GABA reaches the thalamus 4. Increased excitatory outflow from the thalamus to the cortex 5. Selected/desired motor activity increases.
153
The basal ganglia circuit: indirect pathway
1. Striatum receives excitatory, glutamatergic input from cortex 2. Striatum sends inhibitory GABA signal to external Globus pallidus 3. External Globus pallidus produces less of its own GABA 4. Less GABA reaches the subthalamic nucleus 5. Subthalamic nucleus produces more glutamate 6. More glutamate reaches the internal Globus pallidus 7. Intro Globus pallidus produces more of its own GABA 8. More GABA reaches the thalamus 9. Reduced excitatory outflow from the thalamus to cerebral cortex 10. Competing motor activity decreases
154
Substantia nigra
Innervates the striatum, and has tonic dopamine release that promotes movement in a graded fashion by activating the direct pathway and inactivating the indirect pathway
155
Striatum’s dopamine receptor for the direct pathway
D1
156
Striatum’s dopamine receptor for the indirect pathway
D2
157
Hyperdirect pathway
• quickest route through the basal ganglia • cortex excites subthalamic nucleus before it reaches the striatum • stops current movements immediately— interrupts signal
158
Hypokinetic disorders
• direct pathway, inhibited, and/or indirect pathway active • thalamus = more inhibited, less motor activity • bradykinesia, Parkinson
159
Hyperkinetic disorders
• direct pathway active, and/or indirect pathway inhibited • thalamus = less inhibited, more motor activity • dyskinesia, ballismus, Huntington’s
160
Parkinson’s disease
• progressive loss of dopaminergic neurons in substantia nigra pars compacta • Less DA in the striatum • decreased direct pathway, increased, indirect pathway—> inhibition the thalamus • symptoms: bradykinesia, muscle, rigidity, resting, tremor, impaired postural balance
161
Degenerated areas in Parkinson disease
• substantia nigra • locus coeruleus • NE and DA decrease
162
Levodopa (L- DOPA)
• a pro drug, transported across the blood brain barrier buy an amino acid transporter • enzymatically converted to dopamine by L aromatic amino acid decarboxylase (Dopa decarboxylase)
163
Carbidopa
• inhibits, L aromatic amino acid decarboxylase— does not cross the BBB so it only inhibits AAAD in the periphery • can reduce l-dopa those by 75%
164
Mechanism of levodopa
• restores dopaminergic activity in the striatum • activation of D1 receptors—> activation D1, direct pathway • activation of D2 receptors—> inhibits D2, indirect pathway
165
Diphasic dyskinesia
• appears at the onset and offset of the levodopa effect, coinciding with rising and falling plasma levodopa levels • often repetitive, slow movement of the lower limbs off and coinciding with tremors in the upper limbs
166
On- off phenomenon
Sudden and rapid loss of clinical affect. Can last 30 minutes-4 hours, occur up to 10 times per day.
167
Where do we find DA receptors?
• CNS- limbic system and frontal cortex (schizophrenia), other areas • brainstem- chemoreceptor trigger zone outside of the BBB • pulmonary arteries • kidneys
168
Adverse non-motor effects of levodopa
• confusion/anxiety/agitation • psychotic reactions due to high concentrations of dopamine in the CNS • peripheral dopamine effects: orthostatic hypotension, nausea, vomiting, anorexia
169
COMT inhibitors
• entacapone, tolcapone • decrease peripheral metabolism of L-DOPA by catechol-O-methyltransferase (COMT) to 3-OMD • smoother response, more prolonged “on” time
170
Monoamine oxidase inhibitors (MAOIs)
• Selegiline, Rasagiline (more potent) • MAO-A: primarily metabolizes NE and 5-HT • MAO-B: primarily metabolizes dopamine (useful for PD treatment)
171
MAOIs interact with what?
Antidepressants and meperidine. Can cause serotonin syndrome.
172
Dopamine receptor agonist
• pramipexole (D3), ropinirole (D2) • bypass conversion of l-dopa to dopamine • more nausea, hallucinations, peripheral DA symptoms • help with “on-off” fluctuations
173
Amantadine
• antiviral drug acting as a MDMA receptor antagonist • used in early PD patients, benefits are short-lived • adverse effects: agitation, confusion, excitement, hallucinations, psychosis with OD • can cause livedo reticularis- blotchy, netlike red/purple discoloration of the skin
174
Muscarinic antagonist (anti-cholinergics) for PD
• benztropine, trihexyphenidyl • ACh used as neural transmitter for striatal interneurons • mechanism: loss of DA innervation of striatum leads to relative excess of ACh activity
175
Tissue transplantation for Parkinson’s treatment
Human fetal adrenal medullary tissue into caudate nucleus
176
Electrical stimulation for Parkinson’s treatment
Stereotaxic surgical implantation of electrodes into subthalamic nucleus to reduce motor symptoms and smooth out clinical response
177
Surgery treatment for Parkinson’s
• pallidotomy- alleviates akinesia, rigidity and drug induced dyskinesia • thalamotomy- ameliorates tremor
178
Huntington’s disease
• hyperkinetic disorder associated with basal ganglia degeneration (degeneration of striatal neurons projecting to external Globus pallidus) • loss of thalamic inhibition leading to increased excitatory drive and spastic movements
179
Huntington’s disease treatment
• tetrabenazine, Reserpine— inhibit vesicular monoamine transporter (VMAT) • antipsychotics (haloperidol)— dopamine receptor blocking agent • benzodiazepine— helps control anxiety/stress, which can make involuntary movements worse
180
Genetics of Huntington’s disease
• expanded CAG polyglutamine repeats in the Huntington • > 40 repeats = affected full penetrance • autosomal, dominant—> causes death within 10 to 20 years
181
4 tools in the physical exam for UMN versus LMN
1. Tone: muscle tension 2. Strength: amount of force the person can exert 3. Deep tendon reflexes: muscle stretch 4. Gait: walking, combining strength tone and reflexes.
182
Decorticate rigidity
abnormal flexure response, destruction of corticospinal tracts in/very near cerebral hemispheres
183
Decebrate rigidity
Abnormal extensor response, lesion in diencephalon, midbrain, bonds, or severe hypoxia/hypoglycemia
184
Paratonia
• Velocity dependent resistance in response to passive movement, inability to relax. Impacts frontal lobes, can be diffuse cerebellar damage. • seen in late dementia— stiffen and arch back response to touch
185
Special reflexes
• cutaneous, or superficial stimulation reflexes 1. Abdominal reflex- light stroke, T9-11, T11-12 2. Cremasteric reflex: stroke to inner thigh, L1 branches 3. Anal reflex, S2-4
186
Spasticity clinical findings
• UMN, corticospinal tract • hypertonia, clasp knife • common from strokes, or cerebral palsy
187
Rigidity clinical findings
• basal ganglia, extrapyramidal • lead pipe or cogwheel rigidity • Lewy, body disease, supernuclear palsy, Parkinson’s
188
Flaccidity clinical findings
• LMN, from anterior horn cell to peripheral nerves, or UMN in cerebellar disease • hypotonia, loose floppy limbs • Guillian Barre, initial spinal cord injury, or initial stroke symptoms
189
Paratonia clinical findings
• both hemispheres, usually frontal lobe • sudden change in tone with passive ROM (+/-) • dementia
190
Spastic hemiparesis
• stroke • affected arm flexed, at side • affected leg extensors, spastic • circumduction of leg or lean trunk to contralateral side
191
Scissor gate
• cerebral palsy • stiff gait, rigidity • excessive, add duction, internal rotation of leg in the swing movement • short steps • walking through water
192
Steppage gait
• foot drop/radiculopathy at L4/L5 • drag foot or compensate by lifting high • cannot heel walk • tibialis anterior, toe extensor weakness
193
Parkinsonian gate
• stooped posture and poor posture control • slow initiation of movement • short steps and shuffling gait • arm swing decreased • turning is slow and wide based
194
Cerebellar ataxia
• gait broad-based, staggering, unsteady • difficulty with turns • cannot stand steadily with feet together • paired with: dysmetria, nystagmus, intention tremor • cannot stand with feet together
195
Sensory ataxia
• gait broad-based, unsteady • throw feet forward and out with gait, heel first • can stand with feet together, positive Romberg
196
Antalgic gait
It hurts to walk, or use body parts used to walk
197
Types of tremors
Resting, postural, intention (senile)
198
Clinical findings UMN lesion
• weakness • increased reflexes/tone • positive Babinski • spastic paralysis NO: • atrophy • fasciculations/fibrillations • flaccid paralysis
199
Clinical findings of a LMN lesion
• weakness • atrophy • fasciculations/fibrillations • decreased, or absent reflexes/tone • flaccid paralysis NO: • Babinski present • spastic paresis
200
Apraxia
Damage to the motor cortex and association cortex can result in impairments in motor planning and strategies and an inability to perform complex motor tasks— seen in upper motor neuron lesions
201
Hyperkinetic
1. Dyskinesia: abnormal, involuntary movements. 2. Athetosis: slow chorea, riding movements, seen in cerebral palsy/Huntington’s 3. Ballismus: rare, involuntary ballistic movements, most common in stroke and severe hyperglycemia
202
Hypokinetic
1. Akinesia: abnormal, involuntary postures, freezing (Parkinson’s) 2. Rigidity: cogwheel 3. Dystonia: agonist/antagonist muscles, both contract, twisting muscles, abnormal posture 4. Bradykinesia: slow movements, Parkinson’s
203
Cerebrum diseases of UMN
1. Stroke 2. Cerebral palsy 3. Space occupying/structural lesion 4. Degenerative diseases
204
Sub cortex/brainstem diseases of UMN
1. Stroke 2. Degenerative 3. Space occupying/structural lesion— lacunar syndromes, midbrain/brainstem syndromes
205
Spinal cord diseases of UMN
1. Acute transverse myelitis 2. Spinal cord infarct 3. Spinal epidural, or subdural hemorrhage 4. Central intravertebral disc herniation 5. Spinal cord tumors- metastatic or primary
206
Anterior horn disease of LMN
1. Amyotrophic lateral sclerosis 2. Poliomyelitis
207
Spinal nerve root disease of LMN
1. Intravertebral disc herniation
208
Polyneuropathies disease of LMN
1. Guillian Barre syndrome 2. Toxins- puffer fish, shellfish 3. Porphyria 4. Lead/heavy metal poisoning 5. Alcohol/drug induced 6. Diabetic
209
Plexipathies diseases of LMN
1. Brachial 2. Lumbar
210
Peripheral neuropathies diseases of LMN
1. Nerve compression syndromes
211
Spinal nerve issues
L1: hip flexion, groin sensation L2: hip flexion, thigh sensation L3: knee extension, patellar, reflex, knee sensation L4: ankle dorsiflexion, patellar reflex, medial calf sensation L5: first toe dorsiflexion, medial, hamstring reflex, posterior thigh/leg and dorsum of the foot sensation S1: foot movements, Achilles reflex, posterior side, and lateral foot sensation S2: knee, flexor/hamstring, Achilles reflex, back of thigh sensation S2-4: external anal sphincter, anal reflex, perianal area sensation
212
Neuralgia
An intense, typically intermittent pain along with the course of a nerve, especially in the head or face — often described as stabbing, burning, usually severe and can disrupt function (trigeminal neuralgia, shingles, MS, diabetes)
213
Neuropathy
A diffuse situation affecting a region, often peripheral. Can also be described as stabbing, but more commonly is burning or itching. It can be severe (Guillian Barre, chronic demyelinating syndromes, diabetes)
214
ALS vs MS
ALS: combination of upper and lower motor on signs and symptoms MS: can involve upper and lower motor neurons, though is primarily upper motor neurons
215
The difference between a stroke (UMN) and Bell’s palsy (LMN)
Stroke victims can lift their eyebrows on the affected side, while Bell’s palsy cannot
216
The three deadly withdrawal substances
1. Alcohol 2. Barbiturates 3. Benzos
217
Tolerance
Decreased effective drug with repeated administration. Increasing doses of a drug needed to produce a specific affect. — can create cross tolerance to similar drugs, or unequal rate of tolerance development for different drugs
218
Pharmacodynamic tolerance
Cellular response to a Drug, reduced with repeated use
219
Pharmacokinetic tolerance
Decreased quantity of the substance, reaching the site it affects (change in metabolism, transport, etc.)
220
Mesolimbic dopamine system
• prime target of addictive drugs, originating at the ventral tegmental area—> nucleus, accumbens, amygdala, hippocampus, PFC
221
Drugs with higher capacity to cause addiction typically involve:
Dopamine release
222
Sedative hypnotics
1. Benzodiazepine- prolonged activity and decreased immediate reward. Makes it less abusable 2. Short acting barbiturates- high addiction potential 3. Ethanol
223
Effects of sedative hypnotics
• reduce inhibitions, suppress, anxiety, and produce relaxation • respiratory depression at higher doses, facilitation of the effects of GABA • enhance brain DA pathways- related to the development of addiction • flumazenil is an antidote for benzodiazepines
224
Date rape drugs fall into what category?
• sedative hypnotics • flunitrazepam (rohypnol): rapid onset benzodiazepine with marked amnesic properties • gamma- hydroxybutyrate: renders victim incapable of resisting
225
Sedative hypnotic withdrawal symptoms
• excessive CNS simulation: anxiety, tremor, nausea and vomiting, delirium • seizures- life-threatening
226
Sedative hypnotics withdrawal treatments
• administration of a long acting sedative hypnotic— diazepam to suppress acute withdrawal syndrome • clonidine ( alpha-2 adrenergic agonist)and propanolol (beta-adrenergic antagonist) suppress, sympathetic overactivity • naltrexone- treatment alcoholism
227
Nicotine
Effects: rewarding involving the VTA, where the nicotinic acetylcholine receptors are expressed on dopamine neurons Withdrawal: anxiety and mental discomfort- treatment may include varenicline (Chantix) which is a partial agonist of the nicotinic acetylcholine receptors in the VTA
228
Amphetamine- stimulant
Effects: alter transporters of CNS amines (DA, NE) occasionally increasing their release. Euphoria and self-confidence, chronic high-dose abuse, typically treated with benzodiazepines. Withdrawal: abstinence syndrome, increased appetite, sleepiness, exhaustion, mental depression
229
Cocaine- stimulant
Effects: inhibits, the CNS monoamine reuptake. Amphetamine-like effects - overdose: arrhythmias, seizure, respiratory depression. Treatment is benzodiazepines and alpha blockers. Withdrawal: abstinence syndrome, depression. Antidepressant drugs may be indicated.
230
Marijuana
• cannabinoids, backwards, signaling, so Endocannabinoids are retrograde messengers. Signal to the CB1 receptors on presynaptic neurons to increase release of neurotransmitter • effects: euphoria, disinhibition, uncontrollable, laughter, changes, and perception— withdrawal in heavy users
231
Phencyclidine: PCP
• NDMA antagonist - sedative effects, neural impulses cannot travel • violence, impulsivity, psychomotor agitation, analgesia, nystagmus, hypertension, tachycardia, psychosis, seizures • ketamine is also an NDMA antagonist
232
Lysergic acid diethylamide (LSD)
• 5-HT receptor agonist • significant visual and auditory distortion, anxiety, paranoia, psychosis, possible flashbacks in sober state
233
MDMA (ecstasy)
• inhibits/reverses 5-HT transporters affecting NE and DA receptors as well • disinhibition, hyperactivity, hypertension, tachycardia, hyperthermia, serotonin syndrome
234
Opioids- Mu agonists (highest misuse)
• morphine • oxycodone • meperidine • fentanyl • heroin • methadone • Hydromorphone • oxymorphone
235
Opioids- week/partial mu agonists
• codeine • hydrocodone
236
Opioids- mixed agonist-antagonist
• buprenorphine (agonist at mu) • Pentazocine (agonist at kappa) • Nalbuphine (agonist at kappa, antagonist at mu) • butorphanol (agonist at kappa)
237
Opioids- antagonists
• naloxone • naltrexone
238
Dextromethorphan
OTC, anti-tussive, weak mu agonist, Limited abuse potential
239
Loperamide
OTC, anti-diarrheal, mu agonist, action mostly limited to gut, Limited abuse potential
240
The three waves of opioid epidemics
1.) 1990s: increased prescribing of opioids 2.) 2010: rapid increase in overdose deaths involving heroin 3.) 2013: synthetic opioids- illicitly manufactured fentanyl
241
The two ways to decrease the opioid crisis
1.) supply reduction strategies 2.) harm reduction strategies
242
First order kinetics of elimination
Clearance depends on the amount of drug, taking longer as the amount of drug decreases
243
Zero order kinetics of elimination
Clearances linear until the drug is completely gone— independent of amount
244
What do alcohol dehydrogenase & MEOS (CYP2E1) do?
Convert ethanol to acetaldehyde (hangover feeling) — alcohol, dehydrogenase: NAD+—> NADH — MEOS: NADPH + O2—> NADP+ + H2O
245
What does alcohol dehydrogenase do?
Convert acetaldehyde to acetate for elimination (NAD+—> NADH)
246
Alcohol dehydrogenase
• mainly in the liver and gut • metabolizes low to moderate doses of ethanol • zero order kinetics: 7-10 g/hr • ADH1B2: gene that rapidly converts alcohol to acetaldehyde
247
Microsomal ethanol oxidizing system (MEOS)
• CYP2E1 activity is a major component • in the liver only • metabolizes hi ethanol levels (>100mg/dL) • upregulated with chronic alcohol consumption • it converts acetaminophen to a hepatotoxic metabolite
248
Aldehyde dehydrogenase is inhibited by what?
Disulfiram, metronidazole, cephalosporins
249
Ethanol acute effects based on BAC
50-100: sedation, subjective high, slower reaction time 100-200: impaired motor function, slurred speech, ataxia 200-300: emesis, stupor 300-400: coma >400: respiratory depression, death Other effects: depression of myocardial contractility, vasodilation, uterine relaxation
250
Ethanol molecular mechanism
• facilitates the action of GABA at GABA-A receptors • inhibits the ability of glutamate to activate NMDA receptors (black out) • modifies the activities of adenylyl cyclase, phospholipase C, and ion channels
251
Ethanol withdrawals
• hyperexcitability, seizures, toxic psychosis, Delerium tremens (DTs) • DTs: delirium, agitation, ANS instability, low-grade fever, diaphoresis— can cause death • intensity determined by dose, rate, and duration of alcohol consumption
252
Effects on the liver and G.I. tract of alcohol
liver: fatty liver disease—> hepatitis—> cirrhosis—> liver failure GI: irritation, inflammation, bleeding, scarring, increased risk of pancreatitis
253
Effects on the CNS with alcohol
• peripheral neuropathy • Wernicke Korsakoff syndrome: ataxia, confusion, paralysis of extraocular muscles—> coma, death
254
Treatment of alcoholism
• correction of electrolyte imbalances, administration of thiamine, substitute a long acting sedative hypnotic drug such as diazepam • naltrexone • diazepam (causing hangover, feeling because it is an aldehyde dehydrogenase inhibitor)
255
Methanol consumption
• metabolized to formaldehyde and formic acid, causing severe acidosis, retinal damage, blindness • found in windshield, cleaners, and bootleg ethanol
256
Ethylene glycol consumption
• antifreeze, industrial inhalation/skin absorption, or intentional ingestion • metabolized to toxic aldehydes and oxalic acid, causing severe acidosis, renal damage
257
Fomepizole
Inhibits alcohol dehydrogenase to reduce the conversion of methanol to formaldehyde in formic acid, or to reduce the conversion of Ethylene glycol to toxic aldehydes and oxalic acid
258
The hypothalamus is limited at:
The anterior: optic chiasm, and anterior commissure The posterior: the mammillary bodies Medial and lateral regions: fornix
259
Regulation of basic physiological needs by the hypothalamus
1.) controls, blood pressure and electrolytes. 2.) regulates body temperature. 3.) regulates, energy, metabolism, through feeding, digestion, and metabolic rate. 4.) regulates circadian rhythms, and sleep wake cycles. 5.) directs responses to stress 6.) regulates reproduction through hormonal control.
260
Paraventricular nucleus of the hypothalamus
Water balance/stress— oxytocin/vasopressin
261
Anterior hypothalamic area of the hypothalamus
Body temperature— cooling center
262
Supraoptic nucleus of the hypothalamus
Water balance— vasopressin
263
Suprachiasmatic nucleus of the hypothalamus
Biological clock, circadian rhythms, sleep/wake cycles
264
Posterior hypothalamic area
Heating center, responsible for shivering
265
Ventromedial nucleus of the hypothalamus
Satiety— Leptin
266
Mammillary bodies
Under the hypothalamus, responsible for memory. Part of the limbic system.
267
Parvocellular paraventricular nucleus
• medially: secretes hypothalamic releasing hormones, such as CRH and CRF • dorsally and ventrally: neurons project to the medulla and spinal cord to exert autonomic control
268
Magnocellular paraventricular nucleus of the hypothalamus
• two distinct populations, control endocrine function by secreting oxytocin and vasopressin directly into the posterior pituitary
269
Hypothalamic control of endocrine function
• secretes oxytocin and vasopressin into the general circulation from the posterior pituitary (neurohypophysis) • secretes regulatory hormones into the local portal circulation that drains into the anterior pituitary (adenohypophysis) • some hypothalamic neurons influence, peptidergic neurons—> synapsing at those neurons’ cell bodies or axon terminals
270
Lateral hypothalamus
• hunger, activated by ghrelin, lesion causes anorexia
271
Ventromedial hypothalamus
Satiety- activated by leptin, lesion causes over eating, and obesity/ rage
272
Arcuate nucleus
• Thermostat of feeding in the hypothalamus. Responsible for integrating information, and providing inputs to other nuclei in the hypothalamus. • may be regulated by glucose, insulin, Leptin
273
Long-term changes in body fat causes:
• changes in levels of leptin • paraventricular nucleus of the hypothalamus activated • TSH & ACTH secretions are changed from anterior pituitary • sympathetic, and parasympathetic tones change • metabolic rate changes • feeding behavior is regulated
274
Circuitry of the hypothalamus and limbic system
Essential for the normal expression in control of emotions and motivated behavior
275
Circuitry of the hypothalamus and sensory/autonomic system
Provide visceral and somatic sensory input to the hypothalamus and output of the hypothalamus to the control of the ANS
276
Neuro humoral connections
Both sends and receives information by the way of bloodstream (endocrine system) • the pituitary • circumventricular organs
277
Hypothalamus controls ANS function by:
• control of autonomic preganglionic neurons at the parabrachial nucleus, nucleus of the solitary tract, and neurons in the ventrolateral medulla • posterior hypothalamus: heating and sympathetic • anterior hypothalamus: cooling and parasympathetic
278
Circumventricular organs
• several sites I wish the blood brain barrier is highly permeable 1.) organa vasculosum of the lamina terminalis (OVLT) (IL-1, TNF, body temperature, setpoint) 2.) area postrema (vomiting) 3.) pineal gland: melatonin secretion
279
Hypothalamus: neural output and neural input
Controls the autonomic nervous system, emotions
280
Hypothalamus: Neural input, humoral output
Controls release of oxytocin for milk lactation
281
Hypothalamus: humoral input, neural output
Used for drives and motivated behavior
282
Hypothalamus: humoral input, humoral output
Controls release of vasopressin for fluid regulation
283
What contain the magnocellular neurons that secrete oxytocin into the general circulation in the posterior pituitary?
Supraoptic and paraventricular nuclei (Neural input and hormonal output)
284
What is sensitive to osmotic pressure changes?
The supraoptic nucleus containing vasopressin (humoral input, and humoral output)
285
Diabetes insipidus
Caused by lack of or insensitivity to vasopressin = excessive thirst, excessive urination
286
The DSM-V defines a substance use disorder as:
The presence of at least 2 to 11 criteria which are clustered in 4 groups 1.) general impaired functioning— impaired control, taking more drugs for longer than intended, etc 2.) social impairment— failure to fulfill major obligations to to use, etc. 3.) risky behavior/pattern of use— recurrent use in hazardous situations, despite physical or psychological problems 4.) pharmacological dependence— tolerance, and withdrawal
287
Defining severity of SUD
2-3 criteria: mild SUD 4-5 criteria: moderate SUD 6+ criteria: severe SUD • can also indicate remission status (early, sustained, maintained therapy, control environment)
288
Substance related disorders are distinguished from nonpathological substance used by the presence of:
1. Tolerance. 2. Withdrawal. 3. Compulsive use. 4. Substance related problems.
289
Compulsive use in SUD
• drugs, taken in larger amounts, or for longer periods • development of substance centered lifestyle • neglect of significant personal or social interest or obligations • persistent desire to, or unsuccessful attempts at controlling use of a substance
290
Vulnerability phenotypes for SUD
• starting drug use • liking drugs more • continuing drug use • specific to a particular drug (faster high= more addictive)
291
Inheritability for drug abuse ranges from:
40 to 60%
292
Medications for SUD
1.) opioid use disorder: buprenorphine, methadone, naltrexone 2.) opioid, overdose prevention medication: naloxone 3.) medication’s for alcohol use disorder: acamprosate, disulfiram, naltrexone
293
Papez circuit involves (limbic system):
cingulate cortex, hippocampus, fornix, hypothalamus, anterior nuclei of the thalamus, mamillary bodies, amygdala, olfactory bulbs
294
The functions of the limbic system are:
1. Homeostasis 2. Olfaction 3. Memory 4. Emotion and drives
295
Papez circuit:
Hippocampus --fornix--> Mamillary nuclei--mamillothalamic tract--> anterior thalamic nucleus--internal capsule-->cingulate gyrus--cingulum-->parahippocampal gyrus-->entorhinal cortex--alvear/perforant pathways-->Subiculum (hippocampus)
296
Cingulate gyrus
-- Receives input from the thalamus and the neocortex, and projects to the entorhinal cortex via the cingulum -- Involved in emotion formation and processing, learning and memory -- Important in depression and schizophrenia
297
Amygdala
-- Large nuclear group in the temporal lobe -- Integrative center for emotions, emotional behavior, and motivation -- Functions include: Fear, learned fear, anger, and aggression
298
Pathway of amygdala response
input from auditory thalamus/cortex, somatosensory thalamus/cortex --> Lateral nucleus of the amygdala --> central nucleus of the amygdala, central gray, lateral hypothalamus, and paraventricular hypothalamus
299
Fornix and mamillary bodies
--Fornix: major output tract of the hippocampus -- Mammillary bodies: act as relay center for impulses coming from the amygdala and hippocampus. Involved in the processing of memory
300
Korsakoff's syndrome
A chronic memory disorder (loss) caused by a severe deficiency of thiamine (B1). Most common in alcohol misuse, causing damage to the Thalmus and to the mammillary bodies of the hypothalamus
301
Hippocampus
Pathways: entorhinal cortex and fornix, cingulate cortex, temporal lobe cortex, amygdala, orbital cortex, and olfactory bulb all have inputs to the hippocampus via the entorhinal cortex. Functions: Learning and memory, associated with Alzheimer's disease
302
Learning
The ability of previous experiences to modify the inborn reactions or create new ones. It is also the acquisition of knowledge or skills as a result of experiences and can alter behavior.
303
Associative learning
-Classical conditioning: Pavlov, unconditioned stimulus --> conditioned stimulus--> conditioned response -Operant conditioning: Performing a voluntary action in order to receive a reward (positive reinforcement, negative reinforcement, punishment, extinction)
304
Non-associative learning
Habituation: repeated stimulation --> decreased response Sensitization: repeated stimulation --> increased response
305
Learning has 3 stages
1. acquiring: mastering a new activity/concept 2. retaining: keeping the new acquisition for a period of time 3. Remembering: enables one to reproduce the learned act or memorized material
306
Encoding phase of memory
Within the association cortex, information for each memory is assembled from different sensory systems and translated into a form to be remembered
307
Consolidation phase of memory
Converting the encoded information into a form that can be permanently stored. The hippocampal and surrounding areas do this
308
Storage phase of memory
The actual deposition of memories into the final resting places- this is at the association cortex level.
309
Retrieval phase of memory
Memories are of little use if they cannot be read out for later use. Where at is unknown
310
Declarative memory
1. Semantic: Facts 2. Episodic: Events -- Conscious, depend on the medial temporal lobes
311
Non-declarative memory
1. Skills: motor, perception, cognition 2. Priming: perceptual, semantic, judgement 3. Dispositions: classical conditioning, operant conditioning 4. Non-associative: habituation, sensitization
312
Procedural memory
Improving some perceptual or motor skill-- in humans this is not associated with conscious awareness of what is being learned
313
Short term memory
-- Duration: mins-hrs -- Formation of temporary memory traces (newly developed pathway of signal transmission resulting from facilitation of new synapses (new circuits in the brain)
314
How does short term memory occur?
1.) Long term potentiation of synapses 2.) Changes in physical properties of post-synaptic membrane--> increasing sensitivity to chemical transmitters
315
Long term memory
-- Duration: hrs-yrs -- From practice, punishment, or reward -- memory engrams (long-lasting memory traces) -- Formation of new engrams requires protein synthesis
316
Memory engrams are made up by:
1. increase in number of vesicles 2. increase in number of presynaptic terminals 3. increase in release sites of chemical transmitters 4. generation of new receptor sites 5. long term potentiation
317
Brain regions involved in the consolidation of memory
1. hippocampus 2. anterior and lateral temporal lobe 3. Medial temporal lobe 4. Amygdala
318
Patient H.M.
-removed the medial temporal lobe bilaterally to reduce seizures, resulted in inability to form new memories
319
Kluver-Bucy Syndrome
- results from temporal lobe damage, amygdala damage - Caused by herpes encephalitis, and trauma - Characterized by: Amnesia, docility, hyperorality, hypersexuality, and visual agnosia
320
Urbach-Wiethe disease
-lipoid proteinosis - recessive genetic disorder - dermatological symptoms related to general thickening of the skin and mucous membranes, scarring on the skin, easily damaged skin with poor wound healing, dry wrinkly skin - Neurological symptoms related to bilateral symmetrical calcification on the medial temporal lobes
321
Implicit bias
the process of associating stereotypes or attitudes toward categories of people without conscious awareness. It affects behavior
322
Fatphobia
Fear of/aversion to fatness
323
Weight bias
Negative attitudes towards and beliefs about others because of their weight
324
Internalized weight bias
Holding negative beliefs about oneself due to weight or size
325
Weight stigma
The social rejection and devaluation that accrues to those who do not comply with prevailing social norms of adequate body weight and shape
326
What is obesity?
a prevalent, complex, progressive and relapsing chronic disease characterized by abnormal or excessive body fat that impairs health (BMI>30)
327
BMI categories
underweight: <18.5 normal weight: 18.5-25 overweight: 25-30 obesity: >30
328
Weight cycling is correlated with a higher risk of:
Cardiovascular disease and type 2 diabetes
329
When people experience weight stigma:
- eating increases - self-regulation decreased - cortisol levels were higher than controls (cortisol is obesogenic) - increase in all-cause mortality
330
Anorexia nervosa
- BMI < 17.5 - Restriction of energy intake leading to a significantly low body weight - intense fear of gaining weight or being fat, disturbed body inmage - Denial, or pride of control of eating SUBTYPES: Restrictive, binge-eating/purging
331
Atypical anorexia
All of the symptoms of anorexia except a BMI <17.5
332
Bulimia nervosa
- Binge eating and repeated unhealthy behaviors to prevent weight gain ( vomiting, misuse of laxatives or diuretics, food restriction, or excessive exercise) - self-worth based on body shape and weight - weekly behaviors for at least 3 months
333
Bulimia of low frequency and/or limited duration
- purging disorder (no binge eating)
334
Binge eating disorder
- Recurrent episodes of binge eating - associated with eating faster than normal, eating until feeling uncomfortable, eating large quantities of food when not hungry, feeling bad or embarrassed about eating behaviors, - No compensatory behaviors to prevent weight gain - weekly behaviors for at least 3 months
335
Other specified feeding and eating disorder
An eating disorder that does not meet full criteria for one of the main categorized but has specific disordered eating behaviors such as restricting intake, purging/ binging - unclassified disorders
336
Avoidant/restrictive food intake disorder
-avoidance of food intake because of one of the following: lack of interest, sensory characteristics of food, concern about consequences of eating (choking) - associated with weight loss, nutritional deficiencies, and interference with psychosocial functioning - avoidance NOT about weight - Autism SD comorbidity
337
Rumination disorder
- repeated regurgitation of food for at least one month - not attributable to GI or medical condition - No weight concerns
338
Rumination disorder
- repeated regurgitation of food for at least one month - not attributable to GI or medical condition - No weight concerns
339
PICA
- Eating non-nutritive, nonfood substances for at least one month - Eating behavior is developmentally inappropriate that is not culturally supported or socially normative
340
Orthorexia
- not official DSM5-TR diagnosis - Fixation and obsession with eating healthy - Warning signs: compulsive checking of nutrition facts, cutting out food groups, inability to eat anything that is not "pure" or "clean" - high levels of distress when healthy foods are unavailable - obsessive following of food and lifestyle accounts on Social media - body image concerns may or may not be present
341
Bodies affected by eating disorders
- less than 6% of eating disorder people are underweight - 1/3 is male - 42% of men with EDs are gay - Trans students 4x more likely to have disordered eating - Black teenagers 50% more like to binge/purge - Asian americans report more restrictive eating - pregnancy is associated with increased binge eating
342
Comorbidities with EDs
1. Anxiety disorders 2. Mood disorders 3. Impulse control disorder 4. substance use disorders 5. any mental disorders -- Highest comorbidities in Bulimia
343
Anorexia treatments
1. Emergency procedures to restore weight 2. SSRI and atypical antipsychotics (Zyprexa/olanzapine) 3. family based therapy 4. CBT 5. NO WELLBUTRIN (BUPROPION)
344
Family based therapy for anorexia
Phase 1.) empowers parents in promoting healthy eating behaviors and restore weight Phase 2.) autonomy in feeding gradually shifted back to pt Phase 3.) facilitates improved family communication and independence
345
Treatment of Bulimia
- SSRIs (fluoxetine/prozac, escitalopram/lexapro, citalopram/celexa) - anticonvulsants (topiramate/Topamax) - Family based therapy - CBT -NO WELLBUTRIN
346
Treatment of Binge eating disorder
-SSRIs, appetite suppressants, anticonvulsants (topomax), stimulant medication (vyvanse) - CBT -Interpersonal psychotherapy (Phases: 1. identify problems and relation to eating, 2. learn skills to promote interpersonal fxning and reduce disordered eating, 3. maintenance of gains and relapse prevention
347
Physician's role in eating disorder care
1. screening for eating disorders at annual visits 2. medical surveillance/monitor for refeeding syndrome 3. Weigh ins (blind) 4. setting activity restrictions 5. reinforcement of treatment/goals/messages
348
Screening tools for eating disorders
1. EAT-26 (AN) 2. BEDS-7 (BED) 3. SCOFF 4. EDE-Q 5. EDGE symptom survey
349
refeeding syndrome
the potentially fatal shifts in fluids and electrolytes that may occur in malnourished patients receiving artificial refeeding (whether enterally or parenterally5). These shifts result from hormonal and metabolic changes and may cause serious clinical complications.
350
Physiological and endocrine circadian cycles: higher in the day vs at night
Higher in the day: Core body temperature, Urine volume, systolic blood pressure, cortisol Higher at night: Cerebral blood flow, melatonin, thyrotrophin, growth hormone
351
Cellular clock oscillation pathway
light-->retina--> suprachiasmatic nucleus (SCN)--> 2nd messengers--> kinases--> mRNA/DNA modification--> protein--> output signals for sleep/wake
352
Entraining agents of circadian rhythm
- light - melatonin - activity
353
Potential causes of chronic misalignment of circadian rhythm
- Chronotype - Social jet lag - Shift work - Circadian rhythm disorders - disrupted feeding rhythm - psychiatric disorders
354
Circadian rhythm disorders
Jet lag, shift work sleep disorder, advanced sleep phase syndrome (ASPD), delayed sleep phase syndrome (DSPS), non-24 hour sleep wake disorder
355
Circadian clock-related disorders
Cancer, neurological and psychiatric disorders, metabolic syndromes, cardiovascular diseases
356
What disease has a strong alteration in the circadian rest-activity rhythms?
Alzheimer's
357
Sleep is defined as:
A naturally recurring state of mind and body characterized by altered consciousness, relatively inhibited sensory activity, inhibition of nearly all voluntary muscles, and reduced interactions with surroundings
358
What drives sleep?
Process-S (sleep drive) and Process-C (circadian wake drive). The greatest urge to sleep occurs when they are the greatest distance from one another (around 11pm)
359
How is sleep studied?
1. EEG - gross brain wave activity, electroencephalogram 2. EMG - muscle tone measuring, electromyogram 3. EOG - eye movement measurement, electrooculogram
360
Electroencephalogram
- reflects the summation of the synchronous activity of millions of neurons 1.) awake with mental activity: Beta, 14-30 Hz 2.) awake and resting: Alpha, 8-13 Hz 3.) Sleeping: Theta, 4-7 Hz 4.) Deep sleep: Delta, <3.5 Hz
361
Three functional sleep stages of the brain
1.) Awake: beta waves, alpha when eyes closed 2.) Non-REM sleep: Stage 1: Theta waves (light sleep), Stage 2: spindles, K complexes (Slow, long), Stage 3-4: delta waves, highest amplitude, synchronized 3.) REM sleep: Beta waves (similar to awake) -- Movement only occurs in Wake, eye movement occurs in wake and REM
362
Stage 1 sleep
-Drowsiness, eyes move very slowly and muscle activity decreases. - May experience sudden muscle jerks or have a falling sensation - 4-5% of the time
363
Stage 2 sleep
- Light sleep, eye movements stop, and heart rate and breathing decreases, body temp decreases, bruxism - increase wave frequencies (sleep spindles) and increase in wave amplitude (K complexes) - 45-55% of the time
364
Stage 3-4 sleep
- Deep sleep, no eye movements or muscle activity - Slow wave sleep (SWS) - waking would cause groggy feeling or disorientation - bedwetting, night terrors, and sleepwalking occur here - 3 = 4-6% of the time - 4 = 12-15% of the time
365
Stage 5 sleep: REM
- rapid eye movements, heart rate and breathing increase, dreaming occurs, limbs paralyzed, clitoral/penile tumescence occurs - plays a role in memory consolidation, organization of cognition, and mood regulation - 20-25% of the time
366
Neural mechanisms of sleep
1.) Norepinephrine, Locus coeruleus 2.) Serotonin, Raphe nucleus 3.) Acetylcholine, Basal forebrain 4.) Histamine, Midbrain 5.) Orexin, Hypothalamus -- Therefore, SSRIs and SNRIs inhibit REM sleep
367
Ascending reticular activation system
Reticular core of the brain stem in processes that arouse and awaken the forebrain
368
Sleep promoting factors
1. adenosine: inhibits awaking diffuse modulatory systems 2. Caffeine: antagonist of adenosine receptors 3. Melatonin: SCN-PVN-Pineal gland, inhibited by light 4. Nicotine: stimulant, can cause insomnia
369
Orexin/hypocretin
- neuropeptide that regulates arousal, wakefulness, and appetite - Ex. narcolepsy comes from a lack of orexin in the brain in the lateral hypothalamus - orexin binds the two G-protein coupled orexin receptors (GPCR), OX1 and OX2
370
Amine hypothesis (monoamine hypothesis)
Depression associated with changes in serotonin or NE signaling in the brain with significant downstream effects - other NTs/neuropeptides downstream
371
Tricyclic antidepressants (TCAs)
Mech: blocks the reuptake of NE and/or 5-HT by nerve terminals resulting in higher concentration of NTs at the receptors Side effects: antimuscarinic effects, dry mouth, blurred vision, urinary retention, constipation Drugs: Amitriptyline, Desipramine, Imipramine
372
Adverse effects of TCAs
1. orthostatic hypotension 2. Antimuscarinic effects 3. Weight gain 4. Tachycardia and arrhythmias Why? It blocks multiple receptors. Shotgun effect. Reuptake of 5-HT, block histamine H1 receptors, block muscarinic receptors, block alpha1 receptors, block Na channels
373
TCAs are metabolized by
CYP2D6, which is inhibited by fluoxetine (prozac)
374
Monoamine oxidase inhibitors (MAOIs)
- initially from isoniazid for TB (accident) Mech: Blocks the oxidative deamination of monoamines (MAOA, NE and 5-HT, and MAOB, DA) Drugs: Phenelzine (Nardil), and Isocarboxazid (Marplan)
375
Adverse effects and drug interactions of MAOIs
- low therapeutic index (<5) - Contraindicated with other serotonergic drugs (meperidine, methadone, tramadol, dextromethorphan) which can lead to serotonin syndrome - reacts with Tyramine in the diet to increase adrenergic stimulation and increase blood pressure to dangerous levels (foods such as cheese, wine, beer, yogurt, avocados, bananas) and also sympathomimetic amines such as ephedrine, and pseudoephedrine
376
Symptoms of serotonin syndrome
hyperthermia, muscle rigidity, tremors, seizures, autonomic instability, diarrhea, confusion, irritability, and agitation. Can progress to coma and death. Treatment: Cyproheptadine (5-HT2 receptor antagonist)
377
SSRIs
Mech: selective inhibition of serotonin reuptake by CNS neurons- increases the serotonin in synapse Side effects: sexual dysfunction, DO NOT use alone with bipolar disorders (triggers mania), Suicide (black box warning) Drugs: Fluoxetine (Prozac), Sertraline (zoloft), Paroxetine (Paxil), Citalopram (Celexa), Escitalopram (Lexapro)
378
Discontinuation syndrome
Occurs when stopping SSRIs without tapering: dizziness, flulike symptoms, nausea, insomnia, imbalance, and sensory disturbances
379
SNRIs
Mechanism: block serotonin reuptake AND NE reuptake. Unlike TCAs, does not block adrenergic receptors, histaminergic receptors, and cholinergic receptors Side effects: GI distress, sexual dysfunction, discontinuation syndrome ( 5-HT). Increased BP, increased HR, insomnia, anxiety, agitation (NE). Higher dropout rates than SSRIs Drugs: Venlafaxine (Effexor), Duloxetine (cymbalta), Desvenlafaxine (Pristiq- active metab. of venlafaxine)
380
Mirtazapine (Remeron)
Mech: blocks presynaptic alpha-2 receptors on adrenergic neurons and serotonergic neurons (alpha2 normally blocks NE release presynaptically) - Also acts on H1 antagonists (sedation, increased appetite, weight gain)
381
Bupropion (Wellbutrin)
Mech: Enhances both NE and DA neurotransmission by both increasing presynaptic release and inhibiting reuptake Side effects: CNS stimulation (agitation, anorexia, and insomnia), NO sexual side effects Also: smoking cessation- Zyban
382
Trazodone (Desyrel)
Mech: potent 5-HT2A receptor antagoninst and weak selective inhibitor of SERT while little effect on NET. Weak antagonist at alpha-adreneric and H1 receptors Side effects: sedation, GI disturbances, and fewer sexual side effects
383
Ketamine
Mech: injectable anesthetic, potent N-methyl-D-aspartate (NMDA) receptor antagonist - growing evidence for glutamate in depression (post-mortem studies) - single dose improves symptoms of depression in less than two hours, lasting for a week Side effects: nightmares and hallucinations
384
Esketamine
Mech: active S-enantiomer of ketamine, Nasal spray low dose. Needs supervision FDA warning: risk for sedation, difficulty with attention/judgement, abuse/misuse, and SI
385
Brexanolone/Allopregnanolone
Metabolite of progesterone, increases during pregnancy, decreased considerably following childbirth. Potent positive allosteric modulator of GABAA receptors. HELPS WITH post-partum depression
386
Lithium Carbonate (Lithobid, Eskalith)
Drug for Bipolar disorder. Renal clearance of lithium is reduced and 25-40% by THIAZIDE DIURETICS, which can be toxic. Monitor salt levels and renal clearance.
387
Valproic acid (Depakene), or sodium valproate (Depacon)
Anticonvulsant Drug for Bipolar disorder that has efficacy similar to lithium in many cases. Can combine with lithium
388
Anticonvulsants for bipolar disorder
YES: Carbamazepine, Lamotrogine NO: Phenytoin, Phenobarbital
389
Characteristics of psychosis
- impaired behavior - inability to think coherently - inability to comprehend reality - inability to understand disturbance - symptoms may include delusions and hallucinations
390
Psychosis spectrum
mental retardation --> autism --> schizophrenia --> schizoaffective disorder --> bipolar/unipolar disorder
391
Schizophrenia positive symptoms (gained when the disorder began)
- delusions - Disorganized speech - grossly disorganized behavior - catatonic - hallucinations (auditory)
392
Schizophrenia negative symptoms (lost when the disorder began)
- lack of emotion/interest in life - social isolation - affective flattening (blank facial expression) - alogia (difficulty speaking) - inability to keep friends
393
Schizophrenia cognitive symptoms
- disorganized thinking - slow thinking - poor concentration - poor memory - difficulty integrating thoughts, feelings, and behaviors
394
DA dysfunction- goldilocks principle
Psychosis: DA in Limbic system, block D2 receptors for treatment--> leads to Parkinsonism Parkinsonism: DA in striatum, increase DA levels for treatment --> leads to psychosis
395
First generation antipsychotics
- Block D2 receptors causing less downstream G-protein activation - Chlorpromazine (originally antihistamine) - Can make negative symptoms worse because of increase activation of 5-HT (which normally inhibits DA release) - FGAs block D2 in 4/4 pathways causing decrease in positive symptoms and increase in negative symptoms
396
EPSE- extrapyramidal side effects
- drug-induced movement disorders (dystonia, akathisia, parkinsonism, tardive dyskinesia) - Because of the decrease of D2 receptor activation EVERYWHERE when giving first generation antipsychotic
397
Mesolimbic pathway
- Tegmentum (midbrain) --> accumbens (limbic system) - mediated the positive symptoms of schizophrenia - Block D2 DA receptors--> decrease positive symptoms
398
Mesocortical pathway
- Tegmentum (midbrain) --> frontal and limbic cortex - Area of the brain that mediates negative and cognitive symptoms of schizophrenia - Decreasing DA activity may produce or worsen negative symptoms
399
Nigrostriatal pathway
- Substania nigra (midbrain) --> basal nuclei - regulates posture and voluntary movement - Blocking D2 receptors in receptors in striatum resulting in Parkinsonism like syndrome (EPSE) - imbalance of DA and ACh
400
Tuberoinfundibular pathway
- Hypothalamus --> anterior pituitary - DA inhibits prolactin release - Blocking DA in this pathway may result in galactorrhea, amenorrhea, hypogonadism, infertility, erectile dysfunction
401
Second generation antipsychotics
- Clozapine (Clozaril), blocks D2 receptors and 5-HT2A receptors (works on positive and negative symptoms) - Can cause life-threatening AE- agranulocytosis (only use clozapine with WBC monitoring) - Targeted block of 3/4 pathways to decrease negative symptoms
402
Non-clozapine second generation antipsychotics
- risperidone (Risperdal) - Olanzapine (Zyprexa) - Ziprasidone (Geodon) - Aripiprazole (Abilify)
403
Names of first generation antipsychotics
- Chlorpromazine (Thorazine) - Haloperidol (Haldol) - Thiorodazine (Mellaril) - Fluphenazine (Prolixin)
404
second generation antipsychotics adverse effects
- weight gain (most common reason for poor compliance), less common in ziprasidone and aripiprazole - Type 2 diabetes
405
Tardive Dyskinesia
- DA receptor disuse supersensitivity - occurs from discontinuation of of TGAs/SGAs, more common with FGAs (does not occur with clozapine)
406
Other uses of antipsychotics
- Delirium - Dementia - ADHD - Severe depression - Eating disorders - PTSD - OCD - GAD
407
When is a sleep study indicated?
Insomnia from limb movements, or a sleep related breathing disorder
408
Actigraphy
- movement is detected using accelerometers - provides estimate of circadian rhythm, sleep and wakefulness - Helpful for: insomnia, circadian rhythm disorders, assessing insufficient sleep, paradoxical insomnia
409
What is the most common sleep disorder?
Insomnia: Repeated difficulty with sleep initiation, duration, consolidation, or quality that occurs despite adequate time and opportunity for sleep and results in daytime impairment
410
Primary insomnia
- pure insomnia - sleep difficulty is the core of the issue - Occurs > 3 times/week for at least 1 month
411
Secondary insomnia
- Most prevalent - separate underlying factors have led to poor sleep (meds/stressors/etc)
412
What is the most effective treatment for primary insomnia?
Cognitive behavior therapy- long term benefits of treatment response in 70-80% of patients (Sleep hygiene also helps)
413
Medication for insomnia
- Benzodiazepines - non-benzos ( Zolpidem, Zaleplon) - Melatonin agonists - Orexin receptor antagonists (Suvorexant) - Antidepressants (Trazadone) - Diphenhydramine - Antipsychotics - OTCs
414
Etiologies of excessive sleepiness
1.) inadequate sleep duration 2.) Narcolepsy 3.) Idiopathic hypersomnia 4.) post-traumatic hypersomnia
415
Narcolepsy tetrad
1. Hypersomnia 2. Cataplexy (abrupt, transient loss of muscle tone)- type 1 has cataplexy, type 2 does not 3. Hypnagogic (hallucinations) 4. Sleep paralysis
416
First line treatment of narcolepsy
Modafinil
417
Parasomnia
- episodic, often undesirable behaviors that accompany sleep - disorders of NREM - Disorders of REM - sleep related dissociative disorders - sleep enuresis (bed wetting)
418
Somnambulism- Sleep walking
- Eyes usually open - mumble/give inappropriate answers - happens in first few hours of the night (during SWS)
419
Sleep terrors
- Dramatic events, crying, screaming, extreme agitation, fright - Sudden arousal from SWS - Autonomic and behavioral manifestations of intense fear
420
Confusional arousals
-Confusion, disorientation, grogginess - sleep inertia: period of extreme grogginess lasting 15-30 minutes, significant agitation upon awakening
421
Nightmare disorder
- Repeatedly being awakened by disturbing dream and recalling the details of the dream, causing distress - Occurs in REM sleep -Recalling the details is a KEY DIFFERENTIATOR of this and sleep terror disorder
422
Sleep related eating disorder
- episodes of nocturnal eating with partial or complete amnesia - typically high calorie, and weird (cat food, raw coffee grounds, pancake mix, etc) - seen more with EDs - associated with sleep deprivation, substance use/abuse, hypnotic meds (Zolpidem)
423
REM behavior disorder
- abnormal behaviors develop during REM - Act out dreams, eyes usually closed - episodes end with rapid awakening and full alertness, with dream recall - usually in the second half of the night - CAN BE ASSOCIATED WITH PARKINSON DISEASE, dementia with lewy body, and multiple system atrophy
424
Sleep movement disorders
- restless leg syndrome - periodic limb movements - sleep leg cramps - sleep rhythmic movement - Bruxism
425
Restless leg syndrome
- abnormal and unpleasant sensations (paresthesias or dysesthesias) involving lower extremities - worse at rest and at night (circadian pattern) - Check ferritin level for low iron - meds include FIRST LINE: gabapentinoids, and then lithium, sedating antihistamines, SSRIs, and TCAs
426
Dementia
Decline in mental ability that interferes with daily life. Not a disease but a symptom, caused by damage to brain cells, interferes with ability of neurons to communicate (esp in the frontal and temporal lobes)
427
Prevention factors of Dementia
- Top risk factors: age and genetics - Cardiovascular health: damage to brain blood vessels - Physical exercise: increases blood and O2 flow to brain - Mental exercise: stimulating life and social contacts (Nun study) - Diet: heart-healthy mediterranean diet
428
Reversible dementias
1. infections and immunity (fever, autoimmune) 2. Metabolic and endocrine (thyroid, low blood sugar, low/high Na, Ca) 3. Nutrition (dehydration, low B1, B6, B12) 4. Medicational 5. Subdural hematomas 6. poisoning (heavy metals, pesticides, alcohol, rec drugs) 7. Brain tumors (add'l pressure) 8. Anoxia ( Asthma, MI, CO poisoning) 9. Normal-pressure hydrocephalus
429
Delirium
Disturbance in mental abilities, confused thinking, reduced awareness of the environment ONSET: rapid, few hours or days.
430
Differences between dementia and delirium
1. ONSET: delirium is sudden onset, dementia gradually worsens 2. ATTENTION: focus/attention impaired in delirium, not in early dementia 3. FLUCUATION: Delirium symptoms fluctuate throughout the day. In dementia memory and thinking stay fairly constant during the day.
431
Vascular dementia
- Multi-infarct, or post-stroke dementia (10% of cases) - Sudden post-stroke changes in thinking and perception (vs memory loss in AD) - Co-existing stroke symptoms: HA, difficulty walking, numbness, paralysis on one side of face or body
432
Cerebral amyloid angiopathy
amyloid deposition in block vessels causing blockage and decreased elasticity
433
Mixed dementia
- abnormalities linked to more than one cause of dementia - Third most common cause of dementia (under AD and vascular) - Brain changes: hallmark abnormalities of more than one cause of dementia, AD + vascular is the most common, and then tau/amyloid, alpha-syn pathologies seen in atypical Parkinsonism
434
Lewy body dementia
- coritcal alpha-synuclein, A-beta42 plaques, and Tau-NFT - 80% of PD pts develop dementia after 10 years - Familial forms: alpha-synuclein, and LRKK2 - ApoE4 increases the risk of sporadic LBD
435
Lewy body dementia imaging shows:
1.) no hippocampal atrophy 2.) abnormal striatonigral activity (SPECT) 3.) visuospatial or constructional impairment (half or quarter clock)
436
Lewy body dementia treatment
- acetylcholinesterase inhibitors: rivastigmine, donepezil - NDMA receptor blockers: Memantine
437
Frontotemporal dementia (FTD)
- behavioral variant, semantic variant (primary progressive aphasia), and non-fluent variant PPA (Pick's disease)- starts with behavioral (AD starts with memory) - 40% + motor neuron disease, 20% + Parkinsonism, both are from the behavioral variant
438
Behavioral variant FTD
-20% of early onset dementia is FTD - deterioration in behavior and personality, language disturbances, or alterations in muscle or motor functions
439
Semantic PPA (primary progressive aphasia)
anomia for people, places, and objects. Word finding difficulties, and impaired word comprehension
440
Non-fluent PPA (primary progressive aphasia)
slow, labored, and halting speech production and by omission or misuse of grammar
441
Frontotemporal vs Alzheimer's disease
- AGE AT DIAGNOSIS: most FTD is early onset, 40-60s. Alzheimer's is more common with old age - BEHAVIOR/LANGUAGE: alterations in early FTDs vs memory loss in early AD - SPATIAL ORIENTATION: getting lost in familiar places, AD>FTD - HALLUCINATIONS/DELUSIONS: moderate-late AD> FTD
442
Frontotemporal pathology and genetics
1. TDP-43 in 50%, increase FTD with MND 2. Tau <50%, Pick's 3. FUS 10%, rare Genetics: SOD1, Tau (MAPT), TDP-43 and FUS, C9orf72** present in 25% FTD and 25% ALS
443
Chronic traumatic encephalopathy
- repetitive head trauma: boxers, football, hockey, soldiers - Dementia including depression, explosiveness, memory loss - Movement disorders: incoordination, slurred speech, slow movement, tremors, and rigidity - symptoms appear years after trauma. - Most common from Tau buildup and TDP-43
444
Creutzfeldt-Jakob disease
- most common human form of transmissible spongiform encephalopathies or prion disease - Rapidly fatal disorder, months after onset that impairs memory and coordination and causes behavior changes
445
Misfolding: seeded nucleation
oligomers are the most dangerous part of monomer--> mature fibrils. Seeding with oligomer avoids latent/nucleation phase for rapid transmission
446
Neuroanatomy of Depression
1. elevated amygdala activity 2. elevated subgenual anterior cingulate activity 3. diminished hippocampus activity 4. Diminished dorsolateral prefrontal cortex during emotional regulation
447
Depression includes a decrease of what NTs?
- NE -Serotonin - DA
448
Depression sleep physiology changes
- decreased REM latency - repeated nighttime awakenings - decreased slow-wave sleep - increased total REM sleep
449
Altered neurogenesis in depression
- decreased hippocampal volume - decreased neuronal complexity
450
DSM-5 definition of mental disorder
a syndrome characterized by clinically significant disturbances in an individual's cognition, emotion, regulation, or behavior that reflects a dysfunction in the psychological, biological, or developmental processes underlying mental functioning. -- two mood disorder categories: depression, and bipolar
451
Disruptive mood dysregulation disorder
- previously known as childhood bipolar disorder - first diagnosis can only be between 6-18 - Features: persistent irritability and frequent bouts of extreme, out of control behavior
452
Premenstrual dysphoric disorder
- significant affective symptoms that arise in the week before menses and abate shortly after onset of menses - must have at least 5 symptoms: mood lability, irritability, tension, problems focusing, anhedonia, fatigue, problems sleeping - symptoms must be present for a year
453
Major depressive disorder
- depressed mood or loss of interest lasting at least 2 weeks - must have at least 4 add'l symptoms: insomnia, hypersomnia, psychomotor retardation or agitation, significant weight loss or gain, increased/decreased appetite, loss of energy, feeling worthlessness, excessive guilt, difficulty concentrating, thinking, or making choices, recurrent thoughts of death or suicide
454
SIGECAPS
- depression assessment evaluating: Sleep, interest, guilt, energy, concentration, appetite, psychomotor changes, suicidal ideation
455
Major depressive disorder epidemiology:
- onset: 29 years - lifetime prevalence is 20.6% - 2-8% of children ages 4-18 meet criteria - prevalence and manifestation of MDD varies, across lifespan
456
Grief
- affect is dominated by feeling of emptiness and loss - dysphoria comes in waves - capacity for positive emotional experiences - self-esteem remains intact - fleeting thoughts or joining decreased
457
Dysthymia
- chronic depressive disorder for at least 2 years, 1 year for children/adolescents - must have two other symptoms: poor appetite or overeating, sleeping too much or too little, poor self-esteem, trouble concentrating/making decisions, feelings of hopelessness - lifetime prevalence is 6%
458
Depression commonly is comorbid with
- anxiety - substance abuse - ADHD and conduct problems - dysthymia is highly comorbid with personality disorders
459
First line treatment for depression
Therapy: cognitive behavior therapy, behavioral activation therapy SSRIs: Fluoxetine (prozac), Escitalopram (lexapro), sertraline (zoloft), Paroxetine (paxil), Citalopram (celexa)
460
Interpersonal psychotherapy (IPT)
- short-term psychodynamic therapy focused on current relationships
461
Acceptance and commitment therapy (ACT)
- teaches mindfulness, acceptance, and cognitive defusion skills to help individuals live in a psychologically flexible and values-consistent way
462
Problem-solving therapy (PST)
- treatment is aimed at resolving barriers to effective social problem solving as the way in which people cope with stressors is believed to be predictive of the degree to which they will struggle
463
Depression treatments for non-responders to first-line treatment
1.) electroconvulsive therapy (ECT)- intentionally induced brain seizures, side effects include memory loss, headaches, and musculoskeletal problems 2.) Ketamine 3.) Transcranial magnetic stimulation (TMS) 4.) Psychedelic assisted psychotherapy 5.) Deep brain stimulation
464
General personality disorder
- a lasting and pervasive configuration of personality traits that strays from cultural norms, and is expressed inflexibly across a range of social settings, and leads to significant distress or impaired functioning. - Affects Cognition, affectivity, interpersonal functioning, and impulse control
465
Cluster A personality disorders (Weird)
1. Paranoid PD 2. Schizoid PD 3. Schizotypal PD
466
Cluster B personality disorders (wild)
1. Antisocial PD 2. Borderline PD 3. Histrionic PD 4. Narcissistic PD
467
Cluster C personality disorders (worried)
1. Avoidant PD 2. Dependent PD 3. Obsessive PD 4. Compulsive PD
468
Paranoid personality disorder
- Cluster A PD - needs 4 criteria to be met - Criteria include problems with trust, fidelty, reading into situations to make them demeaning or threatening - 0.5-2.5% of population - treatment: rarely seek treatment, lack insight to the disorder, anxiolytics and antipsychotics can be helpful
469
Schizoid personality disorder
- Cluster A PD - needs 4 criteria to be met - criteria includes: choosing solitary activity, little/no interest in sexual experiences, lacks close friends, indifferent to praise or criticism - 1.8% of the population - may be genetically related to autism/ parents cold and aloof - prognosis is poor no effective treatments
470
Schizotypal personality disorder
-Cluster A PD - 5 criteria must be met - Criteria includes: unusual perceptual experiences, bodily illusions, odd thinking and speech, behavior is eccentric or peculiar, they desire friendships but cannot make them - commonly associated with anxiety and depression - 3 % of the population - low dose antipsychotics might help
471
Antisocial personality disorder
- Cluster B personality disorder - 3 criteria must be met - Criteria includes: performing acts that are grounds for arrest, lying, use of aliases or conning others, irritability or aggressiveness, lack of remorse - highly comorbid with substance abuse disorders, strong genetic association - individual therapy treatment plans (group work doesn't work)
472
Borderline personality disorder
- Cluster B personality disorder - 5 criteria must be met - criteria include: frantic efforts to avoid real or imagined abandonment, unstable self-image, impulsivity, marked mood changes, chronic emptiness feelings - 1.4-2% of population - childhood sexual abuse is very common - Treatment: dialectical behavior therapy and low dose antipsychotics, antidepressants, or lithium
473
Histrionic personality disorder
- Cluster B personality disorder - 5 criteria must be met - criteria include: dramatic, strong desire for attention, rapidly shifting and shallow emotional expression, uses physical appearance to draw attention to self, considers relationships to be more intimate than they actually are - 1-3% of the population - hyperresponsive noradrenergic system (heritable) - Treatment: may respond to psychotherapy if less impaired
474
Narcissistic personality disorder
- Cluster B personality disorder - Criteria include: has a grandiose sense of self-importance, preoccupied with fantasies of success, power, beauty, or ideal love, requires excessive admiration, exploitative, envious - 2-16% of the population - more common among men, sometimes heritable - may respond to long-term psychotherapy
475
Avoidant personality disorder
- Cluster C personality disorder - 4 criteria are required - Criteria include: avoids interpersonal contact for fear of criticism, disapproval, or rejection, views self as socially inept, personally unappealing, or inferior to others - 2.1-2.6% of population - modest genetic influence - group therapy might be helpful, unlikely to seek treatment
476
Dependent personality disorder
- Cluster C personality disorder - Typically occurs from poor parental bonding - Criteria include: difficulty making decisions without excessive advice and reassurance, needs others to assume responsibility for major areas of their life, feels uncomfortable or helpless when alone, exaggerated fears of being unable to care for themselves - 2-4% of the population - commonly associated with anxiety and depression - no known treatment
477
Obsessive compulsive personality disorder
- Cluster C personality disorder - criteria include: preoccupation with details, rules, lists, order, etc., perfectionism, excessively devoted to work and productivity, inflexible about matters of morality, ethics, or values, micromanages - 2-8% of the population - less common in younger adults, more common in higher education - treatment: psychotherapy
478
Cognition
process of acquiring and understanding knowledge through our thoughts, experiences, and senses. Cognitive functions include all aspects of human culture and behavior (language, emotion, attention, memory, etc.). Both conscious and unconscious
479
Reductionism
Complex brain fxns emerge from the biological properties of neuron and their interconnections
480
Mind
Sum of operations in an information processing organ powered by a vast number and variety of neurons and the complexity of their interconnections
481
Cortical layers and circuitry
- Connect laterally to other hemisphere or deep nuclei (signal integration - area dedicated to a function is proportional to computational columns involved - Cell types: pyramidal, local axon collateral , stellate, dendrites, descending axon (output)
482
Serial organization of sensory information
- unimodal primary sensory cortex (vestibular, somatosensory, gustatory, olfactory, auditory, visual)--> unimodal secondary cortex (same name as primary) --> multimodal association areas that can select and integrate signals in a seamless perception fashion
483
Association cortex has input from:
Thalamic sensory, motor input, subcortical input (DA from midbrain, NE from brainstem, 5-HT from brainstem, ACh from brainstem and basal forebrain nuclei)
484
Parallel processing
1. Dorsal stream, (magnocellular), Parietal cortex, WHERE? processes motor and spatial information such as: position, motion, speed 2. Ventral, (Parvocellular), Temporal cortex, WHAT? processes objection recognition such as: color, shape, texture
485
Where do the dorsal and ventral pathways converge to form planned behaviors?
Frontal cortex (Orb MVPFC, DLPFC)
486
Lesion in the temporal cortex is associated with:
Agnosias: aware of objects but unable to recognize them
487
Visual agnosia
Cannot recognize things but can draw
488
Prosopagnosia
Cannot recognize faces
489
Auditory agnosia
can hear, but cannot recognize sounds
490
Wernicke aphasia
Left temporal injury: impaired understanding of spoken language, garbled speech
491
Hemispatial neglect
Contralateral neglect syndrome of the WHERE? parietal. Patient ignores image contralateral to injury (half clock drawn, half house drawn, etc)
492
Personal neglect hemispatially
Patient will not dress or wash contralateral side, disowning the arm or leg. They still respond and move to pinprick
493
Parietal association cortex (PAC)
Left side contains the language center (specialization), and the right side supports the left. Object on the left: only R PAC activated Object on the right: L+R PAC activated
494
Left side lesion of the PAC
leads to Right sided compensation (less deficits)
495
Right side lesion of the PAC
Right side cannot be compensated by Left side leading to hemispatial neglect
496
Ventrolateral parietal cortex vs. dorsomedial parietal cortex
VLP cortex: Visual fxn- spatial recognition DMP cortex: Motor fxn
497
Lateral intraparietal area responds to
Retina-centered attention (eye fields)
498
Ventral intraparietal area responds to
Head centered attention (Head turning + eye field)
499
Hippocampal formation
- episodic memory, ability to remember past events regardless of emtional content. Long term memory consolidation - Complex functions related to emotion and episodic (autobiographical) memory - transfers information to neocortex by inducing replay in parietal, temporal, and frontal association cortices
500
Frontal cortex
- Organizes behavior and working memory - executive fxn: selecting and planning appropriate behavioral responses - Phineas Gage :)
501
Dorsolateral PFC (DLPFC)
- organization and planning - motor planning: active maintenance of information relevant to an ongoing behavior - Orb VMPFC --> DLPFC --> premotor cortex --> M1 --> appropriate behvior - LESION: working memory deficits, indifference
502
Motor behavior
Perception --> meaning, purpose --> emotional processes in OVPFC --> influence cognitive processes in DLPFC --> act on premotor and primary motor neurons
503
Premotor cortex is activated:
When the object is handling OR just observed. Presentation of an object translates its physical motor properties into a potential motor act -- Parietal cortex (WHERE) is interconnected with premotor, temporal (WHAT) is not
504
Potential motor acts
1.) sight of object triggers all its properties in parietal (WHERE) cortex (pragmatic opportunities) 2.) temporal (WHAT) cortex extracts the meaning of the object based on the subject's intention 3.) Premotor cortex transforms and opportunity into an appropriate potential motor act (convergence of what and where)
505
Blind sight
Lesion in primary visual cortex. subjects cannot see but can guess correctly (subconscious processing?)
506
Unilateral neglect perception
Lesion in RPAC perceives two houses (one with Left fire) as the same, but still would prefer to live in the house that does not have the fire (even though they cannot see it)
507
Left temporal cortex damage forming agnosia but patients still:
place cards in a slot accurately even though they cannot recognize the shapes-- sensory information is guiding them unconsciously.
508
Injury to perception-forming association cortex results in:
Coma, vegetative state, etc. even if they are still able to receive individual information, they cannot put them together or perceive anything